Neoplasms: all 9,616 studies

Page 35 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.

• Management of Nausea and Vomiting Chemotherapy-induced in NormandyCompletedNCT01440465Results posted
• A Study of Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-056)TerminatedNCT01431534Phase 1Results posted
• Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate CancerCompletedNCT01431391Phase 2Results posted
• A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough PainCompletedNCT01429051Phase 3Results posted
• Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to BoneTerminatedNCT01428219Phase 2Results posted
• A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced CancerCompletedNCT01424566Phase 3Results posted
• Fluorescent Evaluation of Colorectal AnastamosesCompletedNCT01424293Not applicableResults posted
• Phase I Trial of BI 836845 for Various Solid CancerCompletedNCT01403974Phase 1Results posted
• Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and CancerCompletedNCT01397747Results posted
• A Phase 1 Study of LY2835219 In Participants With Advanced CancerCompletedNCT01394016Phase 1Results posted
• A Study of LY2584702 in Participants With Advanced CancerTerminatedNCT01394003Phase 1Results posted
• A Study of LY2228820 in Participants With Advanced CancerCompletedNCT01393990Phase 1Results posted
• Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or CetuximabCompletedNCT01393821Not applicableResults posted
• Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid TumorsCompletedNCT01390818Phase 1Results posted
• Effectiveness of Direct-to-Patient Outreach on Colorectal Cancer Screening Within a Low Income and Diverse PopulationCompletedNCT01385579Not applicableResults posted
• A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic CancerCompletedNCT01373164Phase 1/2Results posted
• Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for CervixCompletedNCT01365156Phase 3Results posted
• Sativex® for Relieving Persistent Pain in Patients With Advanced CancerCompletedNCT01361607Phase 3Results posted
• Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid MalignanciesCompletedNCT01351350Phase 1Results posted
• Evaluation of Molecular Markers in Adrenal TumorsTerminatedNCT01348698Results posted
• Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced CancerTerminatedNCT01347866Phase 1Results posted
• Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic ChemotherapyCompletedNCT01346267Not applicableResults posted
• Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple MyelomaCompletedNCT01345019Phase 3Results posted
• A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid TumorsCompletedNCT01341457Phase 1Results posted
• Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic MalignanciesCompletedNCT01341301Phase 2Results posted
• Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is IndicatedCompletedNCT01332721Phase 1Results posted
• TRC105 in Adults With Advanced/Metastatic Urothelial CarcinomaCompletedNCT01328574Phase 2Results posted
• Umbilical Cord Blood Transplantation In Patients With Hematologic Malignancies Using A Myeloablative Preparative RegimenCompletedNCT01328496Phase 2Results posted
• Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)CompletedNCT01327612Phase 2Results posted
• A Study of EMD525797 in Solid Tumor Patients in JapanCompletedNCT01327313Phase 1Results posted
• A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced MalignanciesCompletedNCT01325441Phase 1/2Results posted
• Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced CancerCompletedNCT01324323Phase 1Results posted
• Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced CancerCompletedNCT01324310Phase 1Results posted
• Yoga Cancer Rehabilitation Study: A Randomized Trial of Adaptive Yoga for Older Cancer SurvivorsCompletedNCT01324102Phase 1/2Results posted
• Risk of Cancer Among Pantoprazole UsersCompletedNCT01322633Results posted
• Trial to Determine MTD of BI 836845 Administered Intravenously Once Every Three Weeks in Patients With Advanced Solid Tumours and Later a Weekly Dosing Schedule in Selected Tumour TypesCompletedNCT01317420Phase 1Results posted
• BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal CancerCompletedNCT01314105Phase 1Results posted
• Gemcitabine and CT-011 for Resected Pancreatic CancerTerminatedNCT01313416Phase 2Results posted
• Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal CancerCompletedNCT01313078Phase 2Results posted
• Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid TumorsTerminatedNCT01311713Phase 1/2Results posted
• Apollo Overstitch, a Treat and Resect ModelCompletedNCT01307813Not applicableResults posted
• Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid LeukemiaCompletedNCT01307579Phase 3Results posted
• Sorafenib and TRC105 in Hepatocellular CancerCompletedNCT01306058Phase 1/2Results posted
• Cryotherapy vs. LEEP to Treat Cervical Intraepithelial Neoplasia (CIN) 2/3 Among HIV-positive WomenCompletedNCT01298596Not applicableResults posted
• Carboplatin and Bevacizumab for Recurrent EpendymomaCompletedNCT01295944Phase 2Results posted
• A Study Of PF-04449913 Administered Alone In Select Solid TumorsCompletedNCT01286467Phase 1Results posted
• A Safety Study in Participants With Advanced Solid TumorsTerminatedNCT01284335Phase 1Results posted
• MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered LymphocytesTerminatedNCT01273181Phase 1/2Results posted
• Tapentadol in Chronic Malignant Tumour Related PainTerminatedNCT01264887Phase 3Results posted
• Sativex® for Relieving Persistent Pain in Participants With Advanced CancerCompletedNCT01262651Phase 3Results posted
• Dose-finding Study of Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) to Treat Cervical NeoplasiaCompletedNCT01256424Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)CompletedNCT01254630Phase 3Results posted
• Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)CompletedNCT01253161Phase 2Results posted
• Study of the Safety and Tolerability of PG545 in Patients With Advanced Solid TumoursTerminatedNCT01252095Phase 1Results posted
• A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid TumorsCompletedNCT01248949Phase 1Results posted
• Umbilical Cord Blood Transplant for Children With Myeloid Hematological MalignanciesCompletedNCT01247701Not applicableResults posted
• A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)TerminatedNCT01243762Phase 1Results posted
• Multi-Tracer Positron Emission Tomography in Patients With Solid TumorsTerminatedNCT01243333Not applicableResults posted
• MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor MalignanciesCompletedNCT01235897Phase 1Results posted
• Intended Use Study of the BD SurePath Plus™ PapTerminatedNCT01234480Results posted
• QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the PancreasCompletedNCT01231347Phase 3Results posted
• A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid TumorsCompletedNCT01226732Phase 1Results posted
• A Study in Advanced CancerCompletedNCT01226485Phase 1Results posted
• Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of ChemotherapyCompletedNCT01222767Phase 2Results posted
• Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological MalignanciesCompletedNCT01221857Phase 1/2Results posted
• CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic CancerTerminatedNCT01218867Phase 1/2Results posted
• Study of Everolimus (RAD001) in Combination With LenalidomideCompletedNCT01218555Phase 1Results posted
• Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal TumorsCompletedNCT01217437Phase 2Results posted
• RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast CancerTerminatedNCT01217411Phase 1/2Results posted
• A Phase 1 Study in Patients With Solid TumorsCompletedNCT01215916Phase 1Results posted
• Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid TumorsCompletedNCT01214668Phase 1Results posted
• A Dose-Escalation Study for Patients With Advanced CancerCompletedNCT01214642Phase 1Results posted
• A Study for Participants With Advanced CancerCompletedNCT01214629Phase 1Results posted
• A Phase 1 Study of LY2874455 in Participants With Advanced CancerCompletedNCT01212107Phase 1Results posted
• Feasibility Study of a 60 Minute Rapid Infusion Rituximab Protocol in Patients With B-cell MalignanciesCompletedNCT01206777Phase 2Results posted
• Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid TumorsCompletedNCT01206465Phase 1Results posted
• Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder CancerTerminatedNCT01200992Phase 3Results posted
• Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Participants With Solid TumorsCompletedNCT01199822Phase 1Results posted
• Rapamycin Therapy in Head and Neck Squamous Cell CarcinomaCompletedNCT01195922Phase 1/2Results posted
• The Use of Light Therapy for Managing Sleep Disturbances in Patients With Advanced CancerTerminatedNCT01193530Phase 2/3Results posted
• Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Participants With Solid TumorsTerminatedNCT01190644Phase 2Results posted
• Cytokine Induced Killer (CIK) Cells In Leukemia PatientsCompletedNCT01186809Phase 2Results posted
• A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD ChemotherapyCompletedNCT01184885Early Phase 1Results posted
• Study of Orally Administered TAK-960 in Patients With Advanced Nonhematologic MalignanciesTerminatedNCT01179399Phase 1Results posted
• Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-DependenceCompletedNCT01178281Phase 3Results posted
• Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid TumorsCompletedNCT01177007Phase 2Results posted
• Evaluation of Food Effect on Pharmacokinetics of VismodegibCompletedNCT01174264Phase 1/2Results posted
• Vitamin D and Omega-3 Trial (VITAL)Active, not recruitingNCT01169259Phase 3Results posted
• A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer PainCompletedNCT01165281Phase 3Results posted
• Reduced Intensity Haploidentical Transplant for Hematological MalignanciesCompletedNCT01162096Phase 1/2Results posted
• Notch Inhibitor in Advanced CancerCompletedNCT01158404Phase 1Results posted
• Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or LeukemiaCompletedNCT01154816Phase 2Results posted
• Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast CancerTerminatedNCT01151215Phase 2Results posted
• A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoiesis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA)CompletedNCT01145638Phase 3Results posted
• Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3)TerminatedNCT01139164Phase 2Results posted
• A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid TumorCompletedNCT01128842Phase 1Results posted
• Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV MelanomaCompletedNCT01127451Phase 2Results posted
• Study of Poly (ADP-Ribose) Polymerase (PARP) Inhibitor E7016 in Combination With Temozolomide in Subjects With Advanced Solid TumorsTerminatedNCT01127178Phase 1Results posted
• Studying An Investigational Drug Crizotinib (PF-02341066) In Non Non-Small Cell Lung Cancer Tumors That Are Positive For Anaplastic Lymphoma Kinase (ALK)TerminatedNCT01121588Phase 1Results posted
• Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell TransplantTerminatedNCT01118013Phase 2Results posted

← Neoplasms overview